A similar study showed that circ-PRMT5 plays an oncogenic role in HCC by modulating proliferation, migration and glycolysis by targeting the miR-188-5p/hexokinase 2 (HK2) axis (90). Here, HK2 is linked to hepatocellular carcinoma.